← SynDRA
QX-314
SynDRA canonical compound SYN1958318 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | MAPK14 | TGFBR1 |
| Mechanism of action | sodium channel blocker |
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- QX 314
- CHEBI:46937
- 2-[(2,6-dimethylphenyl)amino]-N,N,N-triethyl-2-oxoethanaminium
- 2-((2,6-Dimethylphenyl)amino)-N,N,N-triethyl-2-oxoethanaminium
- Ethanaminium, 2-((2,6-dimethylphenyl)amino)-N,N,N-triethyl-2-oxo-
- Tocris-1014
- AC1Q5LWR
- Lopac-L-5783
- UPCMLD-DP014
- AC1L1H0Q
- SCHEMBL93854
- Lopac0_000679
- KBioGR_000191
- BSPBio_001471
- KBioSS_000191
- GTPL2405
- UPCMLD-DP014:001
- CHEMBL1180496
- C16H27N2O
- KBio3_000382
- KBio2_005327
- KBio2_002759
- KBio2_000191
- KBio3_000381
- QX314
- Bio2_000671
- Bio2_000191
- ZINC2037285
- CCG-204765
Look up QX-314 in the interactive SynDRA portal →